CIK 0000882095 · Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943047598
- Phone
- 6505743000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- 4 Open-market sale Director sold 5,000 shares at $125.08 ($625,400)
- 4 Planned sale Director sold 5,611 shares at an average $127.11 ($713,186)
- 4 Planned sale Chairman & CEO sold 10,000 shares at an average $126.54 ($1,265,444)
- 4 Derivatives Options or other derivatives
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- 4 Planned sale Chief Financial Officer sold 2,500 shares at $125.23 ($313,075)
- 4 Planned sale Chief Commercial Officer sold 28,000 shares at an average $125.86 ($3,524,173)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale EVP, Corporate Affairs & GC sold 53,646 shares at an average $122.85 ($6,590,487)
- 144 Insider Sale of Securities
- 13F-HR Other Quarterly Holdings of Institutional Investment Managers
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Results of operations
- 4 Planned sale Chairman & CEO sold 10,000 shares at an average $119.39 ($1,193,926)
Page 9 of 160 · 3,186 filings